| Dr Katrina Copoulos, OD | |
|
410 Fleischmann Way, Carson City, NV 89703-2984 | |
| (775) 882-3977 | |
| (775) 882-3285 |
| Full Name | Dr Katrina Copoulos |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 41 Years |
| Location | 410 Fleischmann Way, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013068048 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 200 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Downtown Vision Inc | 3779840327 | 6 |
News Archive
New research shows that a protein produced by a cancer-causing virus influences a key signaling pathway in the immune cells that the virus infects. This stimulates the cells to divide, helping the virus spread through the body.
It may not be inhaled into the lungs, but smokeless tobacco exposes users to some of the same potent carcinogens as cigarettes.
Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced it has established operations in the United States. Internally and through its partners, the Company has a robust drug development pipeline including programs to treat metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders.
The largest survey ever undertaken of Aboriginal children and families has thrown new light on why most existing intervention programs are failing to produce results needed for overcoming the present levels of Indigenous disadvantage.
China is slated to be officially declared free of the debilitating disease lymphatic filariasis, 15 years ahead of the global elimination target of 2020.
› Verified 9 days ago
| Provider Name | Downtown Vision Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376055913 PECOS PAC ID: 3779840327 Enrollment ID: O20171206002799 |
News Archive
New research shows that a protein produced by a cancer-causing virus influences a key signaling pathway in the immune cells that the virus infects. This stimulates the cells to divide, helping the virus spread through the body.
It may not be inhaled into the lungs, but smokeless tobacco exposes users to some of the same potent carcinogens as cigarettes.
Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced it has established operations in the United States. Internally and through its partners, the Company has a robust drug development pipeline including programs to treat metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders.
The largest survey ever undertaken of Aboriginal children and families has thrown new light on why most existing intervention programs are failing to produce results needed for overcoming the present levels of Indigenous disadvantage.
China is slated to be officially declared free of the debilitating disease lymphatic filariasis, 15 years ahead of the global elimination target of 2020.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katrina Copoulos, OD 410 Fleischmann Way, Carson City, NV 89703-2984 Ph: (775) 882-3977 | Dr Katrina Copoulos, OD 410 Fleischmann Way, Carson City, NV 89703-2984 Ph: (775) 882-3977 |
News Archive
New research shows that a protein produced by a cancer-causing virus influences a key signaling pathway in the immune cells that the virus infects. This stimulates the cells to divide, helping the virus spread through the body.
It may not be inhaled into the lungs, but smokeless tobacco exposes users to some of the same potent carcinogens as cigarettes.
Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced it has established operations in the United States. Internally and through its partners, the Company has a robust drug development pipeline including programs to treat metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders.
The largest survey ever undertaken of Aboriginal children and families has thrown new light on why most existing intervention programs are failing to produce results needed for overcoming the present levels of Indigenous disadvantage.
China is slated to be officially declared free of the debilitating disease lymphatic filariasis, 15 years ahead of the global elimination target of 2020.
› Verified 9 days ago
Mrs. Jennifer Lynne Peterson Highley, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 844 W Nye Ln Ste 104, Carson City, NV 89703 Phone: 775-882-3937 | |
Gary W Abel, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 680 W Nye Ln Ste 102, Carson City, NV 89703 Phone: 775-884-4488 | |
Pritchett Eye Care Associates- Carson Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1987 N Carson St Ste 5, Carson City, NV 89701 Phone: 775-883-2015 Fax: 775-883-5805 | |
Dr. Benjamin Clark Seljestad, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 700 Old Clear Creek Rd, Carson City, NV 89705 Phone: 775-884-2020 | |
Dr. Raymond James Ruckman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 111 W Tenth St, Carson City, NV 89703 Phone: 775-883-4664 Fax: 775-883-4750 | |
Vision Consultants Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3050 N Ormsby Blvd, Carson City, NV 89703 Phone: 775-841-4646 |